Stem cells from bone marrow do well in Mayo heart failure trial

04/17/2013 | Daily Express (London)

Heart function improved for all patients who received autologous, bone marrow-derived stem cells in a trial conducted by the Mayo Clinic's Center for Regenerative Medicine in Minnesota, according to a study in the Journal of the American College of Cardiology. The stem cells were modified to act as cardiac cells before being injected into the patients, who were being treated for heart failure.

View Full Article in:

Daily Express (London)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ